eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL Rebetol Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Updates to formatting
  • Extra statutory information
Updated on 23/01/2012 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 26/09/2011 and displayed until 23/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to information about pregnancy or lactation
Updated on 26/08/2011 and displayed until 26/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to MA holder contact details
Updated on 11/10/2010 and displayed until 26/08/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/09/2010 and displayed until 11/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 15/02/2010 and displayed until 09/09/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 22/01/2010 and displayed until 15/02/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   ribavirin